8-K filing — Flyte Aviation, Inc. (VJET)
Filed: 2026-11-16 AccNo: 0001437749-26-037257 Size: 198 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Stocks · News reference
Aviation revenue grew 150% sequentially, from Q2 2026, to approximately $1.87 millionProprietary digital aviation platform user base surges 185% since its redesign in late May 2026, adding more than 13,000 new accounts
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Filed: 2026-11-16 AccNo: 0001437749-26-037257 Size: 198 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Catheter Precision, a subsidiary of Flyte Aviation (NYSE American: VJET), published a peer-reviewed study in The Journal of Interventional Cardiology demonstrating that its LockeT suture retention device outperforms Abbott's Perclose vascular closure device. The 172-patient study showed LockeT achieved 1.2% access-site complications versus 9.3% for Perclose, with zero device failures compared to 4.7% for Perclose, while maintaining equivalent efficiency in hemostasis and same-day discharge rates.
Flyte Aviation (NYSE American: VJET) reported record Q3 2026 preliminary revenue of $2.15 million, up 110% quarter-over-quarter, with aviation segment revenue increasing 150% sequentially to $1.87 million. The company's redesigned digital booking platform surged 185% in user base to over 20,000 users since its May 2026 launch, generating over $500,000 in direct-to-consumer revenue in Q3. The company is expanding its fleet, entering Caribbean operations, and pursuing Canadian expansion.
Option Care Health jumped 23.8% on reports McKesson and CD&R may acquire it; Freight Technologies led gainers, while NFT Ltd. led decliners.